Advertisement

Topics

Companies Related to "Urinary Tract Infections Pipeline Insight 2018 Report Updated" [Most Relevant Company Matches] RSS

17:32 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "Urinary Tract Infections Pipeline Insight 2018 Report Updated" found in our extensive corporate database of over 50,000 company records.

Showing "Urinary Tract Infections Pipeline Insight 2018 Report Updated" Companies 1–25 of 1,800+

Extremely Relevant

Rochester Medical

It's all about quality of life for Rochester Medical. The company focuses on urinary incontinence and urinary retention treatment products, including male external catheters and urethral inserts for women. The firm's RELEASE-NF catheter is designed to prevent urinary tract infections. Most of the company's products are made of silicone rather than latex to reduce the risk of allergic reactions. Ro...


Relevant

Solace Therapeutics, Inc.

Solace Therapeutics is an emerging medical device company focused on the development of non-surgical office based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). Solace is dedicated to improving the patient's quality of life by eliminating side effects typically associate...

Achaogen, Inc.

Achaogen is a clinical-stage biopharmaceutical company focused on the discovery and development of antibiotics for the treatment of serious infections caused by multi-drug resistant, Gram-negative bacteria. The company’s pipeline includes ACHN-490, an aminoglycoside currently being evaluated in a Phase 2 clinical study for the treatment of complicated ...


Entasis Therapeutics Holdings Inc.

Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Entasis’ anti-infective discovery platform has produced a pipeline of meaningfully differentiated programs which target serious bacterial infections, including ETX2514SU...

GeeWhiz® for Male Urinary Incontinence

Urinary Incontinence Product for men by Leading Edge InnovationsLeading Edge Innovations is the manufacturer of the GeeWhiz® for Male Urinary Incontinence. Merlin Technologies, Inc. is the distributor for the product.Creators of innovative medical products.Our mission Realizing that Male Urinary Incontinence can be a challenging health issue, we strive to develop the best possible alternative to...

Poiesis Medical LLC

Poiesis Medical LLC creates advanced urinary products that improve patient care. The company’s first product, the Duette urinary drainage system, addresses design issues with standard urinary catheters and the clinical complications associated with them. For more information about the company, visit www.poiesismedical.com or call 877-487-5740.

IP&MA, Inc

Since 1996, IP&MA has been assisting health care organizations and related industries prevent infectious and other adverse events. IP&MA's professionals have successfully worked with clients to: Decrease the ventilator associated pneumonia rate in intensive care patients by 29%; providing a cost avoidance of over $160,000 per year. Lower the overall nosocomial infection rate for a long term acut...

Arlington Medical Resources

AMR's Hospital Anti-Infectives Insight Series: Gram-Negative Infections analyzes hospital antifungal prescribing patterns using AMR's comprehensive and highly detailed clinical data in conjunction with primary research and extensive understanding of emerging therapies and forecasts. This report contains U.S. data and examines the reasons behind physicians' product preferences, factors driving hosp...

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs for serious infections such as drug resistance and gram-negative infections. The company has developed an emerging pipeline of p...

Advanced Discovries for Health

We are a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, inflammation and oncology. Using our internal discovery capabilities and our network of pharmaceutical and academic partners, we have assembled a promising pipeline of clinical and preclinical product candidates for the treatment of respiratory tract inf...

National Kidney Foundation

The National Kidney Foundation, with offices throughout the country, is dedicated to preventing and treating kidney and urinary tract diseases, improving the health and well being of individuals and families affected by these diseases and increasing availability of all organs for transplantation. More at www.kidney.org.

NeoTract, Inc.

NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent device designed to treat lower urinary tract symptoms (LUTS).

TRACT Therapeutics, Inc.

TRACT Therapeutics, Inc. is a clinical-stage biotechnology company developing a novel therapeutic approach to restoring immune balance in transplantation and autoimmune disease. It’s proprietary platform technology, using autologous, polyclonally expanded T-regulatory cells was developed at Northwestern University by pioneer, Joseph R Leventhal, MD, P...

BioPharm Insight

BioPharm Insight is the most comprehensive life science market intelligence and analytics solution, featuring a team of investigative journalists writing exclusive news and thousands of healthcare data points, aggregated into one centralized source. In addition to the proprietary articles that are consistently being written, BioPharm Insight is currently t...

EDAP TMS

EDAP TMS S.A. develops and markets Ablatherm, the most advanced and clinically proven choice for High Intensity Focused Ultrasound (HIFU) treatment of localized prostate cancer. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. The company is also developing this technology for the treatment of certain other types of tumors. ED...

Urocare Products Inc

Established in 1975, Urocare has fast become a name synonymous for quality urinary incontinence management products. Over the years, Urocare has turned a single product into an entire line of health care products that have become recognized and requested in countries around the world. These products are patented to protect their unique, practical benefits and are the result of years of research, d...

Solace Therapeutics Inc.

Solace Therapeutics is dedicated to developing innovative, non-surgical and clinically effective devices that address unmet needs in lower urinary tract symptoms (LUTS). Our initial focus is on improving the quality of life for women whose daily life is disrupted by their incontinence. The Company’s venture capital investors include New Enterprise Ass...

UroGen Pharma Ltd.

UroGen Pharma Ltd. (Nasdaq:URGN) is a clinical-stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology, with a focus on uro-oncology. UroGen has developed RTGel™, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles ...

Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals, Inc. is a leading developer of improved treatments for diseases that affect mucosal tissues. Using its proprietary mucus penetrating particle (MPP) technology platform, Kala is able to formulate active pharmaceutical ingredients so they are able to pass through human mucus secretions, in diverse organs, including the respiratory tract...

HealthLeaders-InterStudy

Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly and covering 35 states plus the District of Columbia, each report provides a detailed look at:

BIOTECH Patent News

BIOTECH Patent News is a monthly printed publication that keeps you updated on the latest events in the world of patented biotechnology. This site provides updates on the latest headlines from BIOTECH Patent News, summaries of recently issued US patents, descriptions of biotechnology available for license, and recent commentary and reviews by biotechology legal professionals. BIOTECH Patent Report...

Appili Therapeutics Inc.

Appili is dedicated to identifying, acquiring and advancing novel therapeutics for infectious disease. The company has two anti-infective programs, ATI-1501 and ATI-1503, in its pipeline. ATI-1501 is a taste-masked treatment for anaerobic infections, including C. difficile. Appili’s second product, ATI-1503, is a novel antibiotic with broad potential ...

TARIS Biomedical

TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. The TARIS core technology and development efforts are being applied to disease areas with high unmet medical need in which current therapies or systemic treatments h...

Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs such as the treatment of serious drug-resistant and gram-negative infections. The company has developed an emerging pipeline of ...

Adamed Sp. z o.o.

Our priority is production of ethical drugs. We are leaders on the market of new generation drugs in many therapeutic groups such as cardiology, psychiatry, pulmonology, gynecology and treatment of urinal tract infections.We invest in research that is set to find effective and innovative original drugs which can be used for the most common diseases of our time, diabetes, venous thromboembolism (VT...


More From BioPortfolio on "Urinary Tract Infections Pipeline Insight 2018 Report Updated"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks